No profile data available.
Verrica Pharmaceuticals Inc. (VRCA) is a healthcare company in the antiviral pharmaceuticals industry, based in West Chester, United States, with about 76 full-time employees.
It reported revenue of $7.57 million for fiscal year 2024, up 47.7% from fiscal year 2023, and net income of -$76.58 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $14.34 million. Its market capitalization was $70.60 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States.
Verrica Pharmaceuticals reported $7.57 million in revenue for fiscal year 2024, up 47.7% from $5.12 million in fiscal year 2023. In Q3 2025 revenue was $14.34 million.
$70.60 million as of October 9, 2026.
Listed companies of a similar size in the same industry (antiviral pharmaceuticals) include Siga Technologies, Inc. (SIGA), Invivyd, Inc. (IVVD), Vaxart, Inc. (VXRT), Kalaris Therapeutics, Inc. (KLRS).